STIM
Neuronetics, Inc.
Key Financials
Net Income
$-38998000
↑ 10.8%
Gross Profit
$72.3M
↑ 33.5%
Revenue
$149.2M
↑ 99.2%
Operating Income
$-31436000
↑ 9.0%
EPS (Diluted)
$-0.59
↑ 57.2%
Total Assets
$141.6M
↑ 0.5%
Total Liabilities
$115.3M
↑ 5.7%
Shareholders' Equity
$22.4M
↓ 19.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 5/13/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 10-Q | 5/5/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| 4 | 4/22/2026 | View on SEC |
| EFFECT | 4/10/2026 | View on SEC |
| DEFA14A | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
| CORRESP | 4/8/2026 | View on SEC |
| SCHEDULE 13D/A | 4/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STIM |
| Company Name | Neuronetics, Inc. |
| CIK | 1227636 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 877-600-7555 |